[1] |
chronic hepatitis B Zhu Lingyun, Zhang Maohai Cui Shasha, et al..
Serum IL-12 and IL-18 levels as well as peripheral blood mononuclear cell FOXp3 in patients with
[J]. Journal of Practical Hepatology, 2019, 22(6): 816-819.
|
[2] |
patients with chronic hepatitis B Zhang Yingming, Shen Shuang, Tian Fei, et al..
Prediction of response to peginterferon alfa-2a by blood IFNL4 and IL-28B gene polymorphisms in
[J]. Journal of Practical Hepatology, 2019, 22(6): 828-831.
|
[3] |
Gao Wei, Hou Yong.
Diagnostic efficacy of hepatic fibrosis by liver stiffness measurement in patients with chronic hepatitis B
[J]. Journal of Practical Hepatology, 2019, 22(5): 652-655.
|
[4] |
Bai Yichun, Deng Jihong, Mei Xiaoping.
Efficacy of peginterferon alfa-2b treatment and affecting response factors in patients with chronic hepatitis B
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 490-493.
|
[5] |
Zhang Yafei, Ye Jun, Xie Qinxiu, et al.
Difference in predicting efficacy of significant liver fibrosis by noninvasive liver fibrosis index in different hospitals
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 510-513.
|
[6] |
Wang Baodan, Li Meng, Gao Yu.
Predictive factors of response to interferon-α antiviral therapy in children with chronic hepatitis B
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 345-348.
|
[7] |
Jiang Yi, Liu Bing.
Comparison of clinical features and histopathological activity index between patients with chronic hepatitis B and chronic hepatitis C
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 188-191.
|
[8] |
Hu Hulan, Zhu Mengfei, Shi Junping..
Non-alcoholic fatty liver disease with concurrent chronic hepatitis B: What’s the progress
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 149-152.
|
[9] |
Wang Yaofeng..
Efficacy and safety of tenofovir in the treatment of patients with chronic hepatitis B
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 847-850.
|
[10] |
He Sheng, Zhang Zhen..
What roles of serum IL-17 gene polymorphism in individuals with chronic hepatitis B viral infection
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 855-858.
|
[11] |
Huang Chunming, Yang Zhan, Nie Yuqiang, et al..
Prediction of liver fibrosis by gamma-glutamyl-transpeptidase-to-platelet ratio in patients with chronic hepatitis B viral infection with normal serum transaminase levels
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 859-862.
|
[12] |
Wang Yan, Wu Qiqi, Zhuang Xiaofang, et al..
Polymorphism of blood IFN-γ gene in patients with hepatitis B induced acute-on-chronic liver failure
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 890-894.
|
[13] |
Baoyan, Wang Yun, Xiang Xiaogang, et al..
Prognosis of patients with hepatocellular carcinoma and underlying hepatitis B An
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 924-927.
|
[14] |
Zhou Zhiling, Yin Qian..
Forecasting hepatic activity index and liver fibrosis staging by serum golgiprotein-73 levels in individuals with chronic hepatitis B viral carriers
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 717-720.
|
[15] |
Wang Fangfang, Zhang Guofan, Guo Chunxia, et al..
Clinical efficacy and safety of switching from entecavir to interferon-α in patients with hepatitis B
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 721-724.
|